African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination.

1. nhttps://www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review?page_refer=MapFullEventReport&reportid=33768; Accessed 12 August 2020
2. nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/878255/poa‐ahs‐thailand‐2020.pdf. Accessed 12 August 2020
3. Sánchez-Vizcaíno JM. Control and eradication of African horse sickness with vaccine.. Dev Biol (Basel) 2004;119:255-8.
   pubmed: 15742636
4. Rodriguez M, Hooghuis H, Castaño M. African horse sickness in Spain.. Vet Microbiol 1992 Nov;33(1-4):129-42.
   pubmed: 1481352doi: 10.1016/0378-1135(92)90041-qgoogle scholar: lookup
5. Portas M, Boinas FS, Oliveira E Sousa J, Rawlings P. African horse sickness in Portugal: a successful eradication programme.. Epidemiol Infect 1999 Oct;123(2):337-46.
   pmc: PMC2810767pubmed: 10579455doi: 10.1017/s0950268899002897google scholar: lookup
6. nhttps://www.oie.int/animal‐health‐in‐the‐world/official‐disease‐status/african‐horse‐sickness/. Accessed 12 August 2020
7. nhttps://www.oie.int/index.php?id=169&L=0&htmfile=chapitre_ahs.htm. Accessed 12 August 2020
8. European Commission. Implementing Regulations (EU) 2020/485 of 2 April 2020 amending Annex I to Implementing Regulation EU 2018/659 as regards the entry into the Union of live equidae and of semen, ova and embryos of equidae from Thailand. .
9. nhttps://www.oie.int/standard‐setting/terrestrial‐code/access‐online/. Accessed 12 August 2020
10. nhttps://eur‐lex.europa.eu/legal‐content/EN/TXT/?uri=CELEX:01992L0035‐20080903. Accessed 12 August 2020
11. nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/244348/pb13831‐ahs‐control‐strategy‐20130923.pdf. Accessed 12 August 2020
12. nhttps://www.reuters.com/article/us‐china‐horses‐disease/china‐to‐test‐horses‐in‐border‐areas‐for‐african‐horse‐sickness‐idUSKCN2251CB. Accessed 12 August 2020
13. nhttps://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/3.05.01_AHS.pdf. Accessed 12 August 2020
14. Agüero M, Gómez-Tejedor C, Angeles Cubillo M, Rubio C, Romero E, Jiménez-Clavero A. Real-time fluorogenic reverse transcription polymerase chain reaction assay for detection of African horse sickness virus.. J Vet Diagn Invest 2008 May;20(3):325-8.
    pubmed: 18460619doi: 10.1177/104063870802000310google scholar: lookup
15. Guthrie AJ, Maclachlan NJ, Joone C, Lourens CW, Weyer CT, Quan M, Monyai MS, Gardner IA. Diagnostic accuracy of a duplex real-time reverse transcription quantitative PCR assay for detection of African horse sickness virus.. J Virol Methods 2013 Apr;189(1):30-5.
    doi: 10.1016/j.jviromet.2012.12.014pubmed: 23291102google scholar: lookup
16. Durán-Ferrer M, Agüero M, Zientara S, Beck C, Lecollinet S, Sailleau C, Smith S, Potgieter C, Rueda P, Sastre P, Monaco F, Villalba R, Tena-Tomás C, Batten C, Frost L, Flannery J, Gubbins S, Lubisi BA, Sánchez-Vizcaíno JM, Emery M, Sturgill T, Ostlund E, Castillo-Olivares J. Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness.. Transbound Emerg Dis 2019 Jan;66(1):83-90.
    pmc: PMC6378617pubmed: 30070433doi: 10.1111/tbed.12968google scholar: lookup
17. Weyer CT, Quan M, Joone C, Lourens CW, MacLachlan NJ, Guthrie AJ. African horse sickness in naturally infected, immunised horses.. Equine Vet J 2013 Jan;45(1):117-9.
    pubmed: 22612775doi: 10.1111/j.2042-3306.2012.00590.xgoogle scholar: lookup
18. Weyer CT, Grewar JD, Burger P, Joone C, Lourens C, MacLachlan NJ, Guthrie AJ. Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.. Vaccine 2017 Apr 25;35(18):2504-2510.
    pubmed: 28341113doi: 10.1016/j.vaccine.2017.03.005google scholar: lookup
19. Dennis SJ, Meyers AE, Hitzeroth II, Rybicki EP. African Horse Sickness: A Review of Current Understanding and Vaccine Development.. Viruses 2019 Sep 11;11(9).
    pmc: PMC6783979pubmed: 31514299doi: 10.3390/v11090844google scholar: lookup
20. van Rijn PA, Maris-Veldhuis MA, Potgieter CA, van Gennip RGP. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.. Vaccine 2018 Apr 5;36(15):1925-1933.
    pubmed: 29525278doi: 10.1016/j.vaccine.2018.03.003google scholar: lookup
21. Lulla V, Losada A, Lecollinet S, Kerviel A, Lilin T, Sailleau C, Beck C, Zientara S, Roy P. Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge.. Vaccine 2017 Jul 24;35(33):4262-4269.
    pmc: PMC5518735pubmed: 28625521doi: 10.1016/j.vaccine.2017.06.023google scholar: lookup
22. Dennis SJ, Meyers AE, Guthrie AJ, Hitzeroth II, Rybicki EP. Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine.. Plant Biotechnol J 2018 Feb;16(2):442-450.
    pmc: PMC5787833pubmed: 28650085doi: 10.1111/pbi.12783google scholar: lookup
23. Rutkowska DA, Mokoena NB, Tsekoa TL, Dibakwane VS, O'Kennedy MM. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.. BMC Vet Res 2019 Dec 3;15(1):432.
    pmc: PMC6892175pubmed: 31796116doi: 10.1186/s12917-019-2184-2google scholar: lookup
24. Maree S, Maree FF, Putterill JF, de Beer TAP, Huismans H, Theron J. Synthesis of empty african horse sickness virus particles.. Virus Res 2016 Feb 2;213:184-194.
    pubmed: 26686484doi: 10.1016/j.virusres.2015.12.006google scholar: lookup
25. Scanlen M, Paweska JT, Verschoor JA, van Dijk AA. The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant.. Vaccine 2002 Jan 15;20(7-8):1079-88.
    pubmed: 11803068doi: 10.1016/s0264-410x(01)00445-5google scholar: lookup
26. Kanai Y, van Rijn PA, Maris-Veldhuis M, Kaname Y, Athmaram TN, Roy P. Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.. Vaccine 2014 Sep 3;32(39):4932-7.
    pmc: PMC4148702pubmed: 25045805doi: 10.1016/j.vaccine.2014.07.031google scholar: lookup
27. Aksular M, Calvo-Pinilla E, Marín-López A, Ortego J, Chambers AC, King LA, Castillo-Olivares J. A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.. Vaccine 2018 Nov 12;36(46):7003-7010.
    pmc: PMC6219453pubmed: 30309744doi: 10.1016/j.vaccine.2018.09.065google scholar: lookup
28. Guthrie AJ, Quan M, Lourens CW, Audonnet JC, Minke JM, Yao J, He L, Nordgren R, Gardner IA, Maclachlan NJ. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.. Vaccine 2009 Jul 16;27(33):4434-8.
    pubmed: 19490959doi: 10.1016/j.vaccine.2009.05.044google scholar: lookup
29. El Garch H, Crafford JE, Amouyal P, Durand PY, Edlund Toulemonde C, Lemaitre L, Cozette V, Guthrie A, Minke JM. An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.. Vet Immunol Immunopathol 2012 Sep 15;149(1-2):76-85.
    pubmed: 22763149doi: 10.1016/j.vetimm.2012.06.009google scholar: lookup
30. Chiam R, Sharp E, Maan S, Rao S, Mertens P, Blacklaws B, Davis-Poynter N, Wood J, Castillo-Olivares J. Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).. PLoS One 2009 Jun 22;4(6):e5997.
    doi: 10.1371/journal.pone.0005997pmc: PMC2694985pubmed: 19543394google scholar: lookup
31. Castillo-Olivares J, Calvo-Pinilla E, Casanova I, Bachanek-Bankowska K, Chiam R, Maan S, Nieto JM, Ortego J, Mertens PP. A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.. PLoS One 2011 Jan 26;6(1):e16503.
    doi: 10.1371/journal.pone.0016503pmc: PMC3027694pubmed: 21298069google scholar: lookup
32. Alberca B, Bachanek-Bankowska K, Cabana M, Calvo-Pinilla E, Viaplana E, Frost L, Gubbins S, Urniza A, Mertens P, Castillo-Olivares J. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge.. Vaccine 2014 Jun 17;32(29):3670-4.
    pmc: PMC4061461pubmed: 24837765doi: 10.1016/j.vaccine.2014.04.036google scholar: lookup
33. Calvo-Pinilla E, de la Poza F, Gubbins S, Mertens PP, Ortego J, Castillo-Olivares J. Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation.. Virus Res 2014 Feb 13;180:23-30.
    pubmed: 24333835doi: 10.1016/j.virusres.2013.12.002google scholar: lookup
34. Calvo-Pinilla E, de la Poza F, Gubbins S, Mertens PP, Ortego J, Castillo-Olivares J. Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.. Antiviral Res 2015 Apr;116:27-33.
    pmc: PMC7125940pubmed: 25643968doi: 10.1016/j.antiviral.2015.01.009google scholar: lookup
35. Calvo-Pinilla E, Gubbins S, Mertens P, Ortego J, Castillo-Olivares J. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.. Antiviral Res 2018 Jun;154:132-139.
    pmc: PMC5966619pubmed: 29678552doi: 10.1016/j.antiviral.2018.04.015google scholar: lookup
36. Manning NM, Bachanek-Bankowska K, Mertens PPC, Castillo-Olivares J. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.. Vaccine 2017 Oct 20;35(44):6024-6029.
    pubmed: 28438410doi: 10.1016/j.vaccine.2017.04.005google scholar: lookup
37. Paillot R, El-Hage CM. The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary.. Pathogens 2016 Jun 10;5(2).
    pmc: PMC4931393pubmed: 27294963doi: 10.3390/pathogens5020042google scholar: lookup
38. Monie A, Hung CF, Roden R, CervarixTM WuTC. A vaccine for the prevention of HPV 16, 18-associated cervical cancer. Biologics: Targets and Therapy 2008;2(1):107–13.
39. Volz A, Sutter G. Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.. Adv Virus Res 2017;97:187-243.
    pmc: PMC7112317pubmed: 28057259doi: 10.1016/bs.aivir.2016.07.001google scholar: lookup
40. Mutua G, Anzala O, Luhn K, Robinson C, Bockstal V, Anumendem D, Douoguih M. Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya.. J Infect Dis 2019 Jun 5;220(1):57-67.
    pmc: PMC6548899pubmed: 30796816doi: 10.1093/infdis/jiz071google scholar: lookup
41. Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba NMA, Halwe S, Rohde C, Eickmann M, Volz A, Hesterkamp T, Jambrecina A, Borregaard S, Ly ML, Zinser ME, Bartels E, Poetsch JSH, Neumann R, Fux R, Schmiedel S, Lohse AW, Haagmans BL, Sutter G, Becker S, Addo MM. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.. Lancet Infect Dis 2020 Jul;20(7):827-838.
    pmc: PMC7172913pubmed: 32325037doi: 10.1016/s1473-3099(20)30248-6google scholar: lookup
42. nhttps://www.ema.europa.eu/en/news/new‐vaccine‐prevention‐ebola‐virus‐disease‐recommended‐approval‐european‐union. Accessed 12 August 2020.
43. nhttps://oiebulletin.com/index.php?panorama=03‐4‐ahs‐vaccine‐en&edition=7913&pdf=panorama&article=9711. Accessed 12 August 2020.
44. nhttps://www.oie.int/wahis_2/public/wahid.php/Countryinformation/Countryreports. Accessed 12 August 2020.
45. nhttps://www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review?page_refer=MapFullEventReport&reportid=35575. Accessed 12 August 2020.

Citations

1. Kunanusont N, Taesuji M, Kulthonggate U, Rattanamas K, Mamom T, Thongsri K, Phannithi T, Ruenphet S. Longitudinal humoral immune response and maternal immunity in horses after a single live-attenuated vaccination against African horse sickness during the disease outbreak in Thailand.. Vet World 2023 Aug;16(8):1690-1694.
   doi: 10.14202/vetworld.2023.1690-1694pubmed: 37766699google scholar: lookup
2. de Klerk JN, Gorsich EE, Grewar JD, Atkins BD, Tennant WSD, Labuschagne K, Tildesley MJ. Modelling African horse sickness emergence and transmission in the South African control area using a deterministic metapopulation approach.. PLoS Comput Biol 2023 Sep;19(9):e1011448.
   doi: 10.1371/journal.pcbi.1011448pubmed: 37672554google scholar: lookup
3. Lazić S, Savić S, Petrović T, Lazić G, Žekić M, Drobnjak D, Lupulović D. Serological Examinations of Significant Viral Infections in Domestic Donkeys at the Special Nature Reserve "Zasavica", Serbia.. Animals (Basel) 2023 Jun 21;13(13).
   doi: 10.3390/ani13132056pubmed: 37443854google scholar: lookup
4. Jiménez-Cabello L, Utrilla-Trigo S, Lorenzo G, Ortego J, Calvo-Pinilla E. Epizootic Hemorrhagic Disease Virus: Current Knowledge and Emerging Perspectives.. Microorganisms 2023 May 19;11(5).
   doi: 10.3390/microorganisms11051339pubmed: 37317313google scholar: lookup
5. Taesuji M, Rattanamas K, Kulthonggate U, Mamom T, Ruenphet S. Sensitivity and specificity for African horse sickness antibodies detection using monovalent and polyvalent vaccine antigen-based dot blotting.. Vet World 2022 Dec;15(12):2760-2763.
   doi: 10.14202/vetworld.2022.2760-2763pubmed: 36718334google scholar: lookup
6. Rattanamas K, Taesuji M, Kulthonggate U, Jantafong T, Mamom T, Ruenphet S. Sensitivity of RNA viral nucleic acid-based detection of avian influenza virus, Newcastle disease virus, and African horse sickness virus on flinders technology associates card using conventional reverse-transcription polymerase chain reaction.. Vet World 2022 Nov;15(11):2754-2759.
   doi: 10.14202/vetworld.2022.2754-2759pubmed: 36590111google scholar: lookup
7. Wang Y, Ong J, Ng OW, Songkasupa T, Koh EY, Wong JPS, Puangjinda K, Fernandez CJ, Huangfu T, Ng LC, Chang SF, Yap HH. Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1.. Emerg Infect Dis 2022 Dec;28(12):2446-2454.
   doi: 10.3201/eid2812.220594pubmed: 36417933google scholar: lookup
8. Wibmer CK, Mashilo P. Exploiting V-Gene Bias for Rapid, High-Throughput Monoclonal Antibody Isolation from Horses.. Viruses 2022 Sep 30;14(10).
   doi: 10.3390/v14102172pubmed: 36298728google scholar: lookup
9. Durán-Ferrer M, Villalba R, Fernández-Pacheco P, Tena-Tomás C, Jiménez-Clavero MÁ, Bouzada JA, Ruano MJ, Fernández-Pinero J, Arias M, Castillo-Olivares J, Agüero M. Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses.. Viruses 2022 Jul 15;14(7).
   doi: 10.3390/v14071545pubmed: 35891525google scholar: lookup
10. Socha W, Kwasnik M, Larska M, Rola J, Rozek W. Vector-Borne Viral Diseases as a Current Threat for Human and Animal Health-One Health Perspective.. J Clin Med 2022 May 27;11(11).
    doi: 10.3390/jcm11113026pubmed: 35683413google scholar: lookup
11. Gao S, Zeng Z, Wang H, Chen F, Huang L, Wang X. Predicting the possibility of African horse sickness (AHS) introduction into China using spatial risk analysis and habitat connectivity of Culicoides.. Sci Rep 2022 Mar 10;12(1):3910.
    doi: 10.1038/s41598-022-07512-wpubmed: 35273211google scholar: lookup
12. Fairbanks EL, Brennan ML, Mertens PPC, Tildesley MJ, Daly JM. Re-parameterization of a mathematical model of African horse sickness virus using data from a systematic literature search.. Transbound Emerg Dis 2022 Jul;69(4):e671-e681.
    doi: 10.1111/tbed.14420pubmed: 34921513google scholar: lookup
13. Clemmons EA, Alfson KJ, Dutton JW 3rd. Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences.. Animals (Basel) 2021 Jul 8;11(7).
    doi: 10.3390/ani11072039pubmed: 34359167google scholar: lookup
14. Bunpapong N, Charoenkul K, Nasamran C, Chamsai E, Udom K, Boonyapisitsopa S, Tantilertcharoen R, Kesdangsakonwut S, Techakriengkrai N, Suradhat S, Thanawongnuwech R, Amonsin A. African Horse Sickness Virus Serotype 1 on Horse Farm, Thailand, 2020.. Emerg Infect Dis 2021 Aug;27(8):2208-2211.
    doi: 10.3201/eid2708.210004pubmed: 34287126google scholar: lookup